Every year Governor General David Johnston presents the Canada Council Killam Prize to top academics in recognition of the tremendous contribution these scholars have made in their respective fields. Paul Kennedy meets the 2015 winners to learn more about the inspiration that drives their passion. ** This episode originally aired May 15, 2015.
The 2015 Canada Council Killam Prize winners:
won the Killam Prize for his contribution to the humanities. His passion for early Canadian poetry led him to found
Canadian Poetry Press
. One of his favourite early Canadian poets is Archibald Lampman (1861-1899) and he highly recommends Lampman's poem
Among the Timothy
as an stellar example of early Canadian poetry.
Vijay Bhargava is a pioneer in wireless communication and the winner of the Killam Prize for his contribution to engineering. Over the past 40 years he's lectured in 66 countries around the world and has won awards for his teaching and dedication to students.
is known around the world for her work on neutron stars. She received the Killam Prize for natural sciences. She holds a Canada Research Chair and the Lorne Trottier Chair in Astrophysics and Cosmology at McGill University. She's a Professor of Physics, Associate Dean of Research in the Faculty of Science and Director of the McGill Space Institute.
has written more than 40 books on Canadian politics and many of those books are must-reads for politicians today. He's befriended prime ministers, public servants and politicians of all major parties in his quest to better understand the mechanisms of power in this country. He the 2015 Killam prize recipient for the social sciences and he's the Canada research chair in public administration and governance at the University of Moncton.
Dr. Lorne Tyrrell
is based at the University of Alberta's Department of Medical Microbiology and Immunology. He's the winner of the Killam Prize for his contribution to health sciences. His groundbreaking research in virology led to the world's first oral antiviral treatment for Hepatitis B and he continues his work in the treatment of Hepatitis B and C.